What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Michael F. Berger mostly deals with Internal medicine, Cancer research, Cancer, Genetics and Oncology.
His research in Internal medicine intersects with topics in Diabetes mellitus and Endocrinology.
His Cancer research includes themes of Genetic testing, Evidence-based medicine, Bioinformatics and Pathology.
Michael F. Berger interconnects Mutation, Human genetics, MEDLINE and Genomics in the investigation of issues within Bioinformatics.
Many of his studies on Genetics apply to Computational biology as well.
His Personalized medicine research is multidisciplinary, incorporating perspectives in Topoisomerase inhibitor and Drug discovery.
His most cited work include:
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity (4467 citations)
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity (4467 citations)
- Comprehensivemolecular characterization of clear cell renal cell carcinoma (1909 citations)
What are the main themes of his work throughout his whole career to date?
Michael F. Berger mainly focuses on Internal medicine, Oncology, Cancer research, Cancer and Pathology.
His Internal medicine research is multidisciplinary, relying on both Diabetes mellitus and Endocrinology.
His Oncology research focuses on Germline and how it relates to Germline mutation.
His studies in Cancer research integrate themes in fields like Mutation, KRAS, Gene, Somatic cell and Kinase.
His Gene research is included under the broader classification of Genetics.
His Bioinformatics research extends to Cancer, which is thematically connected.
He most often published in these fields:
- Internal medicine (44.64%)
- Oncology (32.75%)
- Cancer research (28.19%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (44.64%)
- Oncology (32.75%)
- Cancer research (28.19%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Cancer and Germline.
Internal medicine is closely attributed to Germline mutation in his study.
The various areas that Michael F. Berger examines in his Oncology study include Clinical trial, Disease, Chemotherapy and Cohort.
The Cancer research study which covers Mutation that intersects with Lineage.
His Cancer research includes elements of Computational biology, Sequencing data, DNA sequencing and Drug resistance.
His Germline research focuses on subjects like Somatic cell, which are linked to Liquid biopsy.
Between 2018 and 2021, his most popular works were:
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
- Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade (160 citations)
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid (136 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Michael F. Berger focuses on Internal medicine, Oncology, Cancer research, Cancer and Clinical trial.
His work on Prospective cohort study, Disease and Chemotherapy as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His Oncology study incorporates themes from MEDLINE, Lynch syndrome, Cohort and Immunotherapy.
Michael F. Berger combines subjects such as Mutation, Gene, Receptor, Targeted therapy and HRAS with his study of Cancer research.
His research on Cancer focuses in particular on Esophagogastric cancer.
His Clinical trial study combines topics in areas such as Methotrexate, Refractory, Combination therapy and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
